MEF2C and breast carcinoma: Similarly, exosomes released by IL-4-activated macrophages, which specifically contain miR-233, can be transferred to breast cancer cells and promote their invasiveness by regulating the myocyte enhancer factor 2c (Mef2c)-β-catenin signaling pathway (Yang et al., 2011).